Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
Meet us at...
-
Regenerative Medicine: A New Frontier for Therapeutic Intervention (SMR) - Cambridge, UK - 11 March, 2010
-
5th International IBD Meeting - Capri, Italy - 8-10 April, 2010
- see more events.